Published at Mar 4, 2025 7:16 AM by manilatimes.net positive positive Full Year Trading Update **media[556279]** SPHDFSANN.SW Read more →
Published at Feb 10, 2025 7:21 AM by manilatimes.net mixed mixed Santhera Announces Chief Financial Officer Transition with Appointment of Catherine Isted **media[536253]** SPHDFSANN.SWRNUGFRENE.LOXBDFOXB.LMSCL.SN Read more →
Published at Jan 16, 2025 7:11 AM by manilatimes.net positive positive Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia **media[516427]** SPHDFSANN.SW Read more →
Published at Jan 16, 2025 7:11 AM by manilatimes.net positive positive Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy **media[516426]** SPHDFSANN.SW Read more →
Published at Jan 14, 2025 7:12 AM by manilatimes.net positive positive Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE® (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland **media[514192]** SPHDFSANN.SW Read more →
Published at Jan 14, 2025 7:04 AM by investing.com positive positive Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE ® (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland By Investing.com Santhera Receives Positive Recommendation from Scottish Medicines Consortium for the Use of AGAMREE ® (Vamorolone) in Duchenne Muscular Dystrophy Patients in NHS Scotland SPHDFSANN.SWCPRX Read more →
Published at Jan 6, 2025 7:07 AM by manilatimes.net positive positive Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group **media[506399]** SPHDFSANN.SW Read more →
Published at Jan 6, 2025 7:04 AM by investing.com positive positive Santhera Enters into Supply and Distribution Agreement for AGAMREE ® (Vamorolone) with Clinigen Grou By Investing.com Santhera Enters into Supply and Distribution Agreement for AGAMREE ® (Vamorolone) with Clinigen Grou SPHDFSANN.SWCPRX Read more →
Published at Dec 20, 2024 7:21 AM by manilatimes.net positive positive Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy **media[497428]** SPHDFSANN.SW Read more →
Published at Dec 11, 2024 7:11 AM by manilatimes.net positive positive Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy **media[489047]** SPHDFSANN.SW Read more →
Published at Dec 10, 2024 7:19 AM by manilatimes.net positive positive Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy **media[487763]** SPHDFSANN.SW Read more →
Published at Nov 12, 2024 7:29 AM by manilatimes.net positive positive Santhera Enters into Exclusive Supply Agreement for AGAMREE® (Vamorolone) with Ali Al Suwaidi Trading Establishment (ASTE) in Qatar **media[462804]** SPHDFSANN.SW Read more →